|
Sign In to gain access to subscriptions and/or personal tools.
|
Review: New antiplatelet guidelines for managing peripheral arterial disease — what are the implications for diabetes?
Mike Kirby
The Surgery, Nevells Road, Letchworth, Hertfordshire, SG6 4TS, UK, kirbym{at}globalnet.co.uk
Rebecca Gardener
Peripheral arterial disease (PAD) presents a major health problem in the UK and is often over looked because many patients are asymptomatic. The prevalence rises markedly in diabetes. Primary care has an important role in the identification and management of vascular disease and the prevention of secondary events. New guidelines underline the importance of antiplatelet agents.
Key Words: antiplatelet agents diabetes vascular disease claudication.
References
- Peripheral Arterial Diseases Antiplatelet Consensus Group. Antiplatelet therapy in peripheral arterial disease. Consensus statement. Eur J Vasc Endovasc Surg 2003;26:1-16.[Medline]
[Order article via Infotrieve]
- Krentz AJ, Mani R., Shearman CP Peripheral arterial disease in diabetes: time for a co-ordinated approach to management. Br J Diabetes Vasc Dis 2003;3:92-6.[Abstract/Free Full Text]
- Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP, the Vascular Clinical Triallists. Clinical trials for claudication. Assessment of exercise performance, functional status and clinical end points. Circulation 1995;92: 614-21.[Free Full Text]
- Weitz JI, Byrne J., Clagett GP et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996;94:3026-49.[Free Full Text]
- Santilli JD, Santilli SM Chronic critical limb ischemia: diagnosis, treatment and prognosis. Am Fam Physician 1999;59:1899-908.[Web of Science][Medline]
[Order article via Infotrieve]
- Criqui MH, Langer RD, Fronek A. et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.[Abstract]
- Criqui MH, Denenberg JO The generalised nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 1998;3:241-5.[Abstract/Free Full Text]
- Simons PC, Algra A., Eikelboom BC et al. Carotid artery stenosis in patients with peripheral arterial disease: the SMART Study. J Vasc Surg 1999;30:519-25.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Novo S. Classification, epidemiology, risk factors, and natural history of peripheral arterial disease. Diabetes Obes Metab 2002;4(suppl 2):S1-S6.[CrossRef][Web of Science]
- Hirsch AT, Criqui MH, Treat-Jacobson D. et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2003;286. 1317-24.
- Fowkes FG, Housley E., Cawood EH et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.[Abstract/Free Full Text]
- Elhadd TA, Robb R., Jung RT, Stonebridge PA, Belch JJ A Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Pract Diabetes Int 2003;16:163-6.
- MacGregor AS, Price JF, Hau CM et al. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. Diabetes Care 1999;22:453-8.[Abstract]
- Jude EB, Oyibo SO, Chalmers N., Boulton AJ Peripheral arterial disease in diabetic and nondiabetic patients. Diabetes Care 2001;24:1433-7.[Abstract/Free Full Text]
- Boulton AJ Why bother educating the multi-disciplinary team and the patient - the example of prevention of lower extremity amputation in diabetes. Patient Educ Couns 1995;26:183-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tierney S., Fennessy F., Hayes DB ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease. BMJ 2000;320: 1262-5.[Free Full Text]
- Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women
62 years of age. Am J Cardiol 1994;74:64-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - Petersen S., Peto V., Rayner M. Coronary Heart Disease Statistics. http://www.heartstats.org/datapage.asp?id=1652, 2003 (last accessed 8 June 2004).
- Fowkes FG, Price JF, Leng GC Targeting subclinical atherosclerosis has the potential to reduce coronary events dramatically. BMJ 1998;316: 1764-70.[Free Full Text]
- Vowden P., Vowden K. Doppler assessment and ABPI: Interpretation in the management of leg ulceration. http://www.worldwidewounds.com/2001/march/Vowden/Doppler-assessment-and-ABPI.html, 2001 (last accessed 8 June 2004).
- Papamichael CM, Lekakis JP, Stamatelopoulos KS, Papaioannou TG, Alevizaki MK Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 2000;86:615-18.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Belch J., Topol E., Agnelli G., Bertrand M. Critical issues in peripheral arterial disease detection and management. Arch Intern Med 2003;163:88492.
- Shaw JE, Zimmet PZ The epidemiology of diabetic neuropathy. Diabetes Reviews 1999;7:245-52.[Web of Science]
- Shaw JE, Boulton AGM. Diabetic foot. In: Davies AH, Beard JD, Wyatt MG, editors. Essential Vascular Surgery. Philadelphia: WB Saunders, 2001.
- Hiatt WR, Hoag S., Hamman RF Effect of diagnostic criteria on the prevalence of peripheral arterial disease. Circulation 1995;91:1472-9.[Abstract/Free Full Text]
- Criqui MH, Fronek A., Barrett-Connor E. et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-15.[Abstract/Free Full Text]
- Fowkes FGR. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 1988;2:283-91.[CrossRef][Medline]
[Order article via Infotrieve]
- Hiatt WR Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608-21.[Free Full Text]
- Department of Health. National Service Framework for Coronary Heart Disease. http://www.dh.gov.uk/assetRoot/04/01/91/20/04019120.pdf, 2000 (last accessed 8 June 2004).
- Boyle R. DoH explains thinking behind national service framework for coronary heart disease. BMJ 2000;321:1083.[Free Full Text]
- Williams B., Poulter NR, Brown MJ et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 5,
311-315 (2004)
DOI: 10.1177/14746514040040050401

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|